Primary Care Clinics in Vernon, CA Accepting Medicare
5 Primary Care Clinics found. Showing 1 - 5
 U.s. Healthworks Medical Group, Pc Clinic/Center - Multi-Specialty Medicare: Not Enrolled in Medicare Practice Location: 3364 E Slauson Ave, Vernon, CA 90058 Phone: 323-584-7242 |
Technimed Vernon Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 3364 E Slauson Ave, Vernon, CA 90058 Phone: 323-584-7242 Fax: 714-899-4275 |
L.a. Urgent Care General Practice Medicare: Not Enrolled in Medicare Practice Location: 4221 S Alameda St, Vernon, CA 90058 Phone: 323-676-5111 Fax: 323-676-5112 |
Concentra Urgent Care Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 3851 S Soto St, Vernon, CA 90058 Phone: 323-585-7162 Fax: 323-585-0167 |
Stacy Medical Center General Practice Medicare: Medicare Enrolled Practice Location: 4580 Pacific Blvd, Vernon, CA 90058 Phone: 323-584-0779 Fax: 323-584-2282 |
News Archive
Adherence to diabetes medication lowers risk of hospitalization
Individuals with diabetes who adhere to their medication had lower risk of hospitalization by one-third when compared to patients who do not adhere to their medication, according to a new study. The results of the study by Prime Therapeutics (Prime), a thought leader in pharmacy benefit management, are being presented the last week in April at the Academy of Managed Care Pharmacy's 23rd Annual Meeting and Showcase in Minneapolis, Minn.
Nutrition vital for patients recovering from severe burns
For someone recovering from severe burns, eating is often the last thing they want to do. However, burn specialists at The Ohio State University Wexner Medical Center say nutrition is so vital to their patients' recovery that they make it a quality indicator for patient care.
Janssen, Orexo to end OX-CLI/OX-ESI research collaboration and license agreement
Orexo AB and Janssen Pharmaceuticals, Inc., formerly Ortho-McNeil-Janssen Pharmaceuticals, Inc. and Janssen Pharmaceutica NV, have decided to end their research collaboration and license agreement regarding the OX-CLI and OX-ESI programs and a third, undisclosed Janssen program.
Top-line results from Inviragen's INV21 Phase 1 trial on HFMD
Inviragen today reported top-line results of a placebo-controlled, randomized Phase 1 trial of INV21, the Company's highly purified virus particle vaccine against Hand, Foot and Mouth Disease (HFMD) caused by enterovirus 71.
› Verified 2 days ago